News Releases

Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology

July 11, 2023

Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial

May 22, 2023

Anixa Biosciences Clarifies Poster Presentation on Company Website

April 17, 2023

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine

April 17, 2023

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting

March 27, 2023

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

March 13, 2023

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

March 2, 2023

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology

February 27, 2023

Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board

February 21, 2023

Anixa Biosciences to Present at Biotech Showcase 2023

December 19, 2022

Latest News & Events

Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...

Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...

Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...